Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. (Record no. 6150212)

MARC details
000 -LEADER
fixed length control field 01410 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512200509.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198412s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0140-6736
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s0140-6736(84)91506-x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lever, A M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19841227
245 00 - TITLE STATEMENT
Title Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Lancet (London, England)
Date of publication, distribution, etc. Nov 1984
300 ## - PHYSICAL DESCRIPTION
Extent 1062-4 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Agammaglobulinemia
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aspartate Aminotransferases
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Concanavalin A
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C
General subdivision transmission
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis, Viral, Human
General subdivision transmission
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulins
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Intramuscular
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Intravenous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenotype
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element T-Lymphocytes
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Webster, A D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brown, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thomas, H C
773 0# - HOST ITEM ENTRY
Title Lancet (London, England)
Related parts vol. 2
-- no. 8411
-- p. 1062-4
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s0140-6736(84)91506-x">https://doi.org/10.1016/s0140-6736(84)91506-x</a>
Public note Available from publisher's website

No items available.